Does 510(k) equal FDA approval?

No. 510(k) clearances establish substantial equivalence. PMA is a different pathway.

Where do FDA user fees come from?

FY2026 standard 510(k) fee is published on the FDA MDUFA fees page (https://www.fda.gov/industry/fda-user-fee-programs/medical-device-user-fee-amendments-mdufa-fees). Fees change by fiscal year; small-business rates differ. Timeline averages on this page are still planning ranges. Professional review required before business use.

Where is the primary FDA source?

Start with https://www.fda.gov/medical-devices and the MDUFA fee schedule linked above. Source status is tracked (official fee URL attached); this is not an FDA determination.

Start Project

GHMAP

Class II pathway in United States

FDA market-access overview for class ii devices. Planning intelligence only — not a regulatory determination, approval, or clinical decision support.

Source trackedNorth America

Timelines, fees, and workflow steps on this page are illustrative market-access planning inputs. They are not legal advice, regulatory approval, or a guarantee of registration, reimbursement, or market entry. Professional review with primary-source verification is required before business use.

Regulatory metrics

Planning ranges for this country and device class. Label every figure as illustrative until sources are verified.

Regulatory pathway metrics for Class II in United States
Metric	Value	Status
Authority	U.S. Food and Drug Administration (FDA) — 510(k)	Source tracked
Device class	Class II	Example only
Average timeline	~180 days / ~6 months (illustrative)	To be verified
Local representative required	Yes — U.S. Agent (for foreign manufacturers)	To be verified
Government / assessment fee	~$26,067 USD (illustrative)	Source required

Submission workflow

Step-by-step planning outline. Owners and sequence vary by product evidence and authority questions.

01
Confirm product code and predicate strategy
Identify classification regulation, product code, and predicate device(s).
Owner: Manufacturer
02
Complete testing and design controls
Bench, biocompatibility, software, and clinical data as required for substantial equivalence.
Owner: Manufacturer
03
Prepare 510(k) submission
Assemble 510(k) sections, labeling, and performance data.
Owner: Manufacturer
04
Submit to FDA and respond to AI requests
Pay user fees; address Additional Information requests.
Owner: Manufacturer
05
Clearance and US Agent / listing controls
Upon clearance, complete establishment registration/listing; foreign manufacturers appoint a US Agent.
Owner: Manufacturer

Frequently asked questions

Does 510(k) equal FDA approval?: No. 510(k) clearances establish substantial equivalence. PMA is a different pathway.
Where do FDA user fees come from?: FY2026 standard 510(k) fee is published on the FDA MDUFA fees page (https://www.fda.gov/industry/fda-user-fee-programs/medical-device-user-fee-amendments-mdufa-fees). Fees change by fiscal year; small-business rates differ. Timeline averages on this page are still planning ranges. Professional review required before business use.
Where is the primary FDA source?: Start with https://www.fda.gov/medical-devices and the MDUFA fee schedule linked above. Source status is tracked (official fee URL attached); this is not an FDA determination.

Related market-access pages

Cross-links between pathway pages, country intelligence, and certification primers.

Other United States classes

Country intelligence

Broader market, reimbursement, and procurement context for United States.

Open country profile

Related certifications

Convert planning into a scoped GHMAP engagement

Public pathway pages are general context. Product-specific decisions use request-first market entry packages with written scope lock before research begins.

$5,000 · 15 business days after complete intake and scope lock

Full Country Intelligence

Product-specific market-entry decision for one healthcare or MedTech product in one target country. Includes the Decision Report, Evidence & Calculations Workbook, a 60-minute analyst debrief, and one consolidated revision round.

Request Country Intelligence

$7,500 · 20 business days after complete intake and scope lock

Distributor Search & Qualification

Evidence-based distributor search for one defined MedTech or IVD product in one selected country: 10–15 screened candidates, 10 detailed assessments, and 3–5 recommended for outreach when evidence supports it.

Request Distributor Search

Prefer a shorter briefing first? Request a Regulatory Pathway Brief ($1,800).

Market entry packages

Ready to scope United States?

GHMAP confirms written scope before Country Intelligence or Distributor Search research begins. Payment never auto-approves introductions or workspace access.

Start Country Intelligence Read disclaimer

Professional review remains part of every GHMAP deliverable.